A powerful brand-name drug industry trade organization has asked a federal district judge to block Maryland from enforcing the state’s [...] …
Blog Posts
Pharmaceutical giant Eli Lilly has significantly escalated its restrictions on access to 340B pricing in the contract pharmacy setting, the [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
Drug manufacturer Eli Lilly announced a new round of refunds for Humulin, a brand-name insulin, following a 340B ceiling price [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
Fourteen years after the Congressional deadline, the long-anticipated revision to the 340B Administrative Dispute Resolution (ADR) process officially took effect [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
A U.S. senator introduced a bill to extend 340B eligibility to certain outpatient rural hospitals with emergency services, mirroring a [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
Spending on pharmaceuticals in the 340B drug discount program went from nearly $7 billion in 2010 to $44 billion by [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
HHS and Congress should each take long-proposed actions—including a contentious action to curb certain Part B prescribing incentives—to better ensure [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
A key argument in AstraZeneca’s lawsuit challenging Arkansas’ 340B contract pharmacy access law has already been rejected by a higher [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
Drug manufacturer Novartis uses contradictory, “whiplash-inducing” arguments in its lawsuit challenging Mississippi’s 340B contract pharmacy law, hospital groups told a [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
Despite its importance, the 340B drug discount program rarely ever goes under the Congressional spotlight. In fact, until the June [...] …